Our method for lyophilizing Escherichia coli extracts allows for dried cell extracts to be stockpiled more densely than standard aqueous extracts while maintaining viability for cell-free protein synthesis (CFPS). Dried cell extracts stored at room temperature retain protein synthesis viability 60 days after aqueous extracts are effectively rendered useless by degradation and contamination. This method has the potential to decrease extract storage expenses, allow for longer shelf-life of cell extracts at room temperature, and enable durable portable protein production technologies such as pharmacy-on-a-chip microfluidic devices.
Cell-free protein synthesis (CFPS) is a powerful in vitro transcription/translation tool for rapid and efficient production of recombinant proteins. Compared with in vivo protein production, directly accessible cell-free systems provide superior control over the synthesis environment, higher product selectivity, and faster expression of recombinant genes (1) (2) (3) . These attributes make cell-free technology an excellent platform for high-throughput recombinant expression and synthetic biology technologies (1, (4) (5) (6) (7) (8) . Exploiting the benefits of CFPS, myriad proteins have been produced, such as virus-like particles (9, 10) , proteins containing unnatural amino acids (11) (12) (13) , cytotoxic proteins (9) , and a variety of biocatalytic enzymes (14, 15) .
CFPS has been successfully demonstrated with biochemical machinery extracted from many different organisms and cells types, such as wheat-germ, rabbit reticulocytes, insects, yeast, and HeLa cells (5, 16) . In this work, we focus on the most prevalent, least expensive, and generally highest yielding cell-free system, which is based upon Escherichia coli extract (5) .
Prepared cellular extracts for CFPS are commonly stored at -20°C or -80°C prior to use in order to maintain protein synthesis viability (17) (18) (19) (20) . This necessitates a fairly significant capital equipment investment in the form of low or ultralow temperature freezers, their maintenance, emergency backup freezers, and emergency backup power. These storage considerations are particularly cumbersome when stockpiling large quantities of extract for applications such as rapid vaccine and/or therapeutic production in response to a pandemic. A further limitation of storing the CFPS extracts below freezing temperatures is the inability to easily transport for mobile use applications.
One possibility for improving CFPS extract storage efficiency and utility is to lyophilize the extracts. Lyophilizing or freeze-drying simple protein solutions is a commonplace process to remove the volatile liquids, leaving behind a protein powder. This technique reduces the storage volume and is thought to slow the rate of protein degradation. We hypothesized that lyophilizing E. coli cell extracts would similarly reduce storage volume and potentially allow for longer shelf-life at temperatures above -80°C. Lyophilized cell-free systems are commercially available, and previous studies have reported successful synthesis of various proteins using rehydrated lyophilized extracts (21) (22) (23) (24) (25) . However, a straightforward method to produce a lyophilized E. coli-based cell-free system has yet to be detailed in literature. Furthermore, the impact of lyophilization and storage at non-standard temperatures on protein synthesis performance has yet to be described. Here we report a straightforward method for lyophilizing E. coli extract for CFPS using standard machinery. The lyophilized extracts allow for higher density storage and maintain a higher protein synthesis viability at non-standard storage temperatures than aqueous extracts. This simple method provides a viable and convenient alternative to traditional storage strategies by reducing storage costs, protecting extract viability and promoting CFPS accessibility. 
Materials and methods
Cell extract preparation Cells were grown and extracts were prepared as previously described (3, 26) . All growth stages were performed at 37°C in LB media with shaking at 280 rpm. Briefly, Escherichia coli strain BL21-Star (DE3) (Life Technologies, Carlsbad, CA) was inoculated overnight in 5 mL volumes. Overnight growths were transferred to 500 mL baff led shake f lasks containing 100 mL media. The intermediate growths were monitored to an OD 600 of 2 and transferred to 2.5 L Tunair shake flasks (IBI Scientific, Peosta, IA) containing 1 L of media. Growths were induced with 1 mM IPTG (GoldBio, St Louis, MO) at an OD 600 of 0.4-0.7 and grown until mid-to late-log phase (an OD 600 of 2.0 in this work). Cells were harvested, washed, homogenized, and prepared using the streamlined method described previously (3, 27) .
Lyophilization of extracts
Three extract types were lyophilized: (i) standard extract (xSTD lyo ), (ii) extract supplemented with 0.05 g per mL sucrose as a lyoprotectant (xSUC lyo ), and (iii) a ready-to-use mixture of extract and small molecules necessary for phosphoenolpyruvate-energized CFPS ([xSTD+ePEP] lyo ). Lyophilization took place in 5 mL volumes as follows: Samples were loaded into 70 mL cylindrical glass vials for shell freezing in a -40°C ethanol bath (Just-ATilt Shell Freezer Chiller SF-4Az, FTS Systems, Warminster, PA) and incubated for a minimum of 5 min. Vials were transferred to the freeze dryer (Flexi-dry MP, FTS Systems) for 20 min periods. The operating conditions of the freeze dryer were -60°C and <120 mTorr, with a 19°C-20°C ambient temperature. At the end of each 20 min drying period, vials were placed in the -40°C shell freezer for 1 min and subsequently replaced onto the freeze dryer. Lyophilization continued in this manner until at least 95% of the estimated water mass was lost (typically 3 cycles), at which time the vials were chilled on the shell freezer for 1 min, then placed back on the freeze dryer for an additional 60 min to provide for removal of the more tightly interacting water molecules. Lyophilized product was gently ground using a chemical spatula in a glass vial, aliquoted by mass, and stored in sealed microcentrifuge tubes.
Energy systems
An aqueous phosphoenolpyruvate-based energy system (ePEP aqu ) was employed as the primary aqueous energy source for CFPS reactions, as previously described (28) . The powdered versions of the ePEP aqu energy system (ePEP pow ) and a glucosebased energy system (eGLU pow ) were used with slightly adapted reagent amounts as indicated below (29) . ePEP pow contained 0. A separate solution of amino acids and a separate solution of spermidine and putrescine were prepared. The spermidine and putrescine were kept separate due to their extremely hydrophilic nature. Once all componentsexcluding amino acid mix and spermidine/ putrescine mix-were weighed out, they were combined in a 15 mL conical tube and mixed until homogeneous. The powder energy mixes were divided into carefully weighed aliquots ranging from 0.04 to 0.06 g. When suspended in water for CFPS reactions, 4.157 and 5.377 mL water per gram powder were added to the PEP and glucose energy sources, respectively. The hydration volumes (mL water per gram energy powder) were evaluated such that the final density of powdered components in hydrated powder systems equaled the density of components in prepared aqueous systems (Supplementary Material).
Rehydrating extracts and cell-free protein synthesis DC assays (Bio-Rad, Hercules, CA) were performed on samples of untreated aqueous extract and rehydrated extract following the manufacturer's specifications with BSA as the control protein. Lyophilized extract was rehydrated in water according to the optimal ratio determined in the DC assay (Supplementary Material).
Cell-free protein synthesis reactions were performed on each extract type as previously described (30) . In brief, reactions contained 25% v/v extract, 25% v/v energy source, 12 nM plasmid encoding the GFP reporter protein (pY71-sfGFP), and an optimized magnesium glutamate concentration (in this study: 9 mM). Reagents were combined in microcentrifuge tubes and pipetted into a 96-well flat-bottom opaque plate in 20 µL aliquots as droplets in the center of each well. After the wells were sealed, the plate was incubated for 3 h at 37°C. Following the reaction, 45 µL water was added to each well to dilute the reaction over the bottom surface of the well. Resulting GFP fluorescence was measured using a Synergy Mx microplate reader (BioTek Instruments, Inc., Winooski, VT), and protein yield was determined using a linearly correlated calibration curve, as previously detailed (26) .
Bacterial contamination
To monitor for potential bacterial contamination of the extracts, liquid extracts or lyophilized extracts rehydrated with sterile ultrapure water were diluted in sterile SOC media and plated on LB Agar Miller plates. Plates were incubated for 24 h, at which point colonies were counted.
Results and discussion
Cell-free protein synthesis (CFPS) affords many benefits over in vivo synthesis systems, such as open access to the synthesis environment, rapid expression of recombinant PCR-products, and easy application of in vitro synthetic biology. An additional advantage of CFPS is that cell extracts can be produced in large batches and stockpiled for future use (31) . However, the extract is traditionally stored at -80°C to (28) eGLU pow Powder mix of glucose-based energy system 1 (29) maintain viability, increasing the storage expense and complicating transport of the extract. Here we demonstrate that straightforward lyophilization of E. colibased CFPS extracts (i) significantly reduces storage volume, (ii) stabilizes the extract at higher than ideal storage temperatures, and (iii) decreases bacterial contamination.
We also propose and demonstrate that powdered energ y systems may be utilized to create a CFPS system that can be stored at high density and easily transported. E. coli cell extracts (Table 1) were prepared as reported previously in preparation for lyophilization (26) . Two lyophilized extracts types were prepared: (i) standard extract (xSTD lyo ) and (ii) standard extract with sucrose as a potential lyoprotectant (xSUC lyo ). The total mass loss was measured directly and percentage water loss was calculated based on DC assay analysis (Supplementary Material), as seen in Figure 1 , A and B. In all cases, drying removed more than 97% of the estimated original liquid content from the extracts. The removal of the majority of liquid content immediately reduced the storage volume over 2-fold and storage mass over 9-fold.
Lyophilized extracts were ground into powders to promote homogeneity and then aliquoted by mass for storage at -80°C, -20°C, 4°C, and 27°C. Each lyophilized extract had a unique consistency. xSTD lyo had the consistency of well-milled wheat f lour and was easily ground into a fine homogenous powder. The fine powder was easily compressed, allowing for 2-3 times the storage density of liquid extract. xSUC lyo formed sticky heterogeneous granules, making it somewhat difficult to achieve homogeneity and compressed storage.
In preparation for cell-free reactions, extract powders were suspended in sterile ultrapure water. To establish a baseline for rehydration, xSTD lyo was rehydrated at multiple levels, and the DC assay was used to determine the volume-to-mass ratio corresponding to a protein density equivalent to that of xSTD aqu (Supplementary Material). From this baseline, the rehydration volume:mass ratio was established for xSTD lyo and calculated for xSUC lyo (Supplementary Material).
Extracts were tested for protein-synthesis viability over extended storage times with the results displayed in Figure 2 . Notably, xSTD aqu performed equally well at -80 and -20°C over the span of 90 days, suggesting that -80°C storage may not be required for long-term viability of CFPS extracts. Indeed, even at 4°C, xSTD aqu maintained effectively all of its activity through 30 days. When stored at 27°C, xSTD aqu exhibited exponential decay in synthesis performance with effectively no activity by day 60.
xSTD lyo and xSUC lyo initia l ly maintained an average 85% of the protein synthesis viability of xSTD aqu . Extract viability was retained when stored at -80°C, while increasing storage temperatures corresponded to increasing extract degradation rates. Notably, xSTD lyo and xSUC lyo stored at room temperature maintained about 20% protein synthesis viability at day 90. In contrast, xSTD aqu stored at room temperature retained less than 2% viability by day 30. In short, the lyophilized extracts retained significantly higher protein synthesis viability than the liquid extracts when stored for more than 30 days above freezing.
The addition of sucrose as a lyoprotectant to extracts prior to lyophilization did not appear to be beneficial (Figure 2 ). Sucrose and other protein lyoprotectants theoretically stabilize proteins from becoming denatured during the drying and rehydration process (32) . However, lyoprotectants are typically utilized to protect purified proteins in solutions that contain one or a few different types of proteins. In the case of extracts, the complex mixture of proteins and other small molecules in solution may contain components that fill the role of stabilizing proteins during drying, making the addition of sucrose unnecessary.
To identif y potential causes of lost extract viability at higher storage temperatures, we examined bacterial contamination. Lysis efficiency using a high-pressure homogenizer such as that used for this work has been reported to be 99.9996% (26) . Prior to lysis, cell concentrations are approximately 600 billion per mL, thus even at 99.9996%, prepared extracts can have upwards of 2.4 million cells per mL extract. Bacterial contamination was measured in colonies per µL extract plated (Supplementary Figure S2) . Regardless of storage conditions, xSTD aqu had the highest amount of contamination, with an effective cell lysis efficiency of 99.99998% for xSTD aqu stored at -80°C. After 14 days, xSTD aqu stored at room temperature was too contaminated to quantify accurately, and total CFPS viability dropped significantly, suggesting that bacterial growth likely played a role in degrading the extract. In contrast, xSTD lyo showed zero colonies after 30 days at room temperature and retained CFPS viability (Supplementary Figure S2) . Straightforward lyophilization of extracts lays the foundation for high-density and long-term storage of CFPS systems. However, extracts must be provided with an energy source and essential building blocks to successfully transcribe mRNA and translate protein. Typically, energy sources for CFPS are stored as solutions at -80°C due to the temperature sensitive nature of high-energy components such as nucleoside triphosphates, nicotinamide adenine dinucleotide, coenzyme A, and phosphoenolpyruvate (PEP). In powdered formats, high-density mixtures of energy-rich components are less likely to suffer degradation. We therefore considered powdered energy systems as a possible alternative to aqueous storage.
PEP-based energy systems are some of the highest yielding CFPS energy systems (33, 34) . We developed two PEP-based powdered energy systems: (i) a mix of extract and a PEP-based energy system subsequently lyophilized into powder ([xSTD+ePEP] lyo ) and (ii) a powder mix of individual components for a PEP-based energy system (ePEP pow ) (Table 1) (34). To produce [xSTD+ePEP] lyo , a 1:1 aqueous solution of xSTD aqu to ePEP aqu was lyophilized as described above. The resulting powder exhibited a sticky heterogeneity similar to xSUC lyo .
[xSTD+ePEP] lyo was maintained at -80°C or -20°C to mitigate extract degradation effects caused by higher temperature storage, as seen in xSTD lyo and xSUC lyo . ePEP pow was stored across all temperatures to check for temperature sensitive degradation specific to the energy system.
The temperature sensitive nature of many ePEP pow components compelled us to propose a more stable powdered energy system. We consulted the previously reported alternative energy systems consisting of components less sensitive to temperature (3, 28, 29, 35 ) (Supplementary Material). A powdered glucose-based system (eGLU pow ) was selected based on the stability of its components to compare with powdered ePEP pow . Glucose is significantly cheaper than PEP, and glucose-based energy systems have been reported to reduce protein yield expenses compared with PEP-based systems (3). Also, glucose is quite stable in crystal form. To further increase the stability of the glucose-based system, nucleotide triphosphates were replaced with their monophosphate counterparts.
Rehydrating the powdered energy systems in small volumes made it more challenging to achieve a proper pH. The PEP in ePEP pow has a low pKa, yet remains primarily insoluble below pH 6. For [xSTD+ePEP] lyo , pH is addressed prior to lyophilization, and the appropriate pH and buffer ingredients are adjusted prior to lyophilization. However, ePEP pow pH must be considered at the time of hydration. To address this concern, NaOH was added to the hydration mix at an optimized level (Supplementary Figure S3) .
CFPS using the powdered energy systems initially produced high protein yields, as seen in Figure 3 . Indeed, pH-optimized ePEP pow outperformed aqueous ePEP aqu . Comparisons of these two systems' reveal that pH-optimized ePEP pow has a lower pH than ePEP aqu , suggesting that the ePEP aqu system would benefit from pH-optimi- Figure S4) . Initial yields from eGLU pow were very low, totaling less than 5% of the ePEP aqu , which was not unexpected based on previous work (3). Over the 60 day storage time, ePEP aqu performed surprisingly well at elevated storage temperatures, maintaining over 25% viability at room temperature ( Figure  3 ). This result was unexpected due to the purported instability of its components. eGLU pow yields remained low throughout storage, but remained relatively consistent with no observable loss in yields, suggesting it is quite stable. However, the low yields produced with eGLU pow severely limit the utility of such a CFPS system. The powdered PEP-based energy systems, [xSTD+ePEP] lyo and ePEP pow , maintained a minimum of 35% of the viability of the ePEP aqu over 60 days. Although [xSTD+ePEP] lyo displayed upwards of 95% viability compared with xSTD aqu , with ePEP aqu , the lyophilized system exhibited significant inconsistencies in performance. Inconsistent performance of [xSTD+ePEP] lyo is likely due to the difficulty in homogenizing the sticky lyophilized powder. ePEP pow with optimized pH performed well over time at all storage conditions. Indeed, at 60 days, ePEP pow stored at room temperature retained more than 33% of its original viability, over 30% more than ePEP aqu .
The straightforward methods of extract lyophilization and powdered energy systems presented here allow for high-density storage of eCFPS systems. These powdered systems are also more stable than their aqueous counterparts, permitting (i) more economic storage, (i) simplified transport conditions, and (i) a simplified just-addwater protein synthesis system. These benefits make powdered CFPS systems compelling candidates for promising Figure 3 . CFPS yields from aqueous and powdered energy systems stored at various temperatures. Standard storage for CFPS energy sources is in an ultralow freezer at -80°C. Here, systems were stored at -80°C, -20°C, 4°C, and room temperature (27°C ± 3°C) and reacted using xSTD aqu stored at -80°C. The first data point (day 1) corresponds to one day after lyophilization or mixing of the powder. Error bars represent one standard deviation of protein yields and error contributed to hydrating the powders. n = 3. applications such as pharmacy-on-a-chip microfluidic devices for rapid on-the-site treatment and rapid large-scale vaccine or therapeutic protein production from stockpiled extract. Indeed, the development of lyophilized extract and powdered energy systems for CFPS reduces the cost, simplifies the procedure, and expands the viable applications of CFPS technology.
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